Summary
Two metabolites of 5-fluorouracil (FU), monofluoroacetic acid (FA) and α-fluoro-β-alanine (FBAL), were continuously administered into the left ventricle of the brain in cats for up to 1 month to investigate the mechanissm of neurotoxicity of FU and its derivatives. The cumulative doses of FU and FBAL over a 1-month period were 1.5–45 mg (20 cats) and 0.2–4.8 mg (21 cats), respectively. As controls for each experimental group, acetic acid (AA) and β-alanine (BAL) were administered. In terms of survival time in relation to the cumulative dose and molecular weight, FBAL was more toxic than FA. Neuropathologically, two types of change, vacuoles and necrosis/softening-like change, were found. The vacuoles were 20–50 μm in diameter, and distributed mainly in the cerebellar nuclei, white matter and the tectum and tegmentum of the brain stem in both experimental groups. Electron microscopically, these vacuoles were due to splitting of the myelin intraperiod line or separation between the axon and the innermost layer of myelin. Necrosis/softening-like change occurred preferentially in the FBAL group and was located symmetrically in the superior and inferior colliculi, oculomotor nuclei and thalamus. Both types of neuropathological change, especially those in the FBAL group, were similar to those found in cats orally administered with FU and its derivatives. It was, therefore, concluded that the subacute and chronic neurotoxicity of FU and its derivatives in dogs and cats is due to intoxication with the monofluorinated organic metabolites, FA and FBAL, and that the direct action of FA and FBAL on myelin and the action of FBAL on energy metabolism or vessels of the mid brain were proposed as the main pathogenetic factor involved.
Similar content being viewed by others
References
Butler W (1989) The neuropathology of vigabatrin. Epilepsia 30 [Suppl 3]:S15-S17
Chenoweth MB (1949) Monofluoroacetic acid compounds. Pharmacol Rev 1:383–424
Graham D (1989) Neuropathology of vigabatrin. Br J Clin Pharmacol 27:43S-45S
Griffin JW (1979) Neurotoxicity of misonidazole in rats. Neurotoxicology 1:299–312
Jasper HH, Ajmone-Marsan C (1954) A stereotaxic atlas of the diencephalon of the cat. The national Research Council of Canada, Ottawa, pp 14–15
Jubb KV, Saunders LZ, Coates HV (1956) Thiamine deficiency encephalopathy in cats. J Comp Pathol 66:217–227
Kuzuhara S, Ohkoshi N, Kanemaru K, Hashimoto H, Nakanishi T, Toyokura Y (1987) Subacute leucoencephalopathy inducing by carmofur, a 5-fluorouracil derivative. J Neurol 234:365–370
Okeda R, Karakama T, Kimura S, Toizumi S, Mitsushima T, Yokoyama Y (1984) Neuropathologic study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dog. Acta Neuropathol (Berl) 63:334–343
Okeda R, Shibutani M, Matsuo T, Kuroiwa T (1988) Subacute neurotoxicity of 5-fluorouracil and its derivative, carmofur, in cats. Acta Pathol Jpn 38:1255–1266
Pattison FLM, Peters SRA (1959) Toxic aliphatic fluorine compounds. In: Browning E (ed) Elsevier monographs “Industrial toxic agents”. Elsevier Publishing Company, Amsterdam London New York Princeton, pp 1–81
Pattison FLM, Peters SRA (1966) Monofluoroaliphatic compounds. Handbook of experimental pharmacology, vol 20, part 1, Springer, Berlin Heidelberg New York, pp 387–458
Shibutani M, Okeda R (1989) Experimental study on subacute neurotoxicity of methotrexate in cats. Acta Neuropathol 78:291–300
Yamashita K, Sutou H, Maruden A, Takenouchi T, Morita K, Ariyoshi T (1988) A nine-month chronic toxicity study of tegafur-uracil mixture (UFT) in dogs. J Toxicol Sci 13:97–132
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Okeda, R., Shibutani, M., Matsuo, T. et al. Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and α-fluoroβ-alanine. Acta Neuropathol 81, 66–73 (1990). https://doi.org/10.1007/BF00662639
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00662639